Indicated for: bacterial infections
Route of administration: injectable
Substance: amikacin (aminoglycoside antibiotic)
ATC: J01GB06 (Antiinfectives for systemic use | Aminoglycoside antibacterials | Other aminoglycosides)
Amikacin is an antibiotic from the aminoglycoside class, used to treat severe bacterial infections caused by gram-negative bacteria, such as urinary tract infections, respiratory infections, or sepsis. It works by inhibiting bacterial protein synthesis, leading to bacterial destruction.
Amikacin is usually administered intravenously or intramuscularly, with the dosage adjusted based on the patient's weight, the severity of the infection, and renal function. Treatment is typically short-term to reduce the risk of toxicity.
Side effects may include kidney function impairment (nephrotoxicity), auditory nerve damage (ototoxicity), and allergic reactions. For this reason, patients receiving amikacin should be closely monitored, particularly for renal and auditory function.
Amikacin is an effective option for treating severe infections, but its use must be carefully supervised to minimize associated risks. It is important that the medication is used as directed by a specialist physician.
NHP 1.A (C2) - People with HIV/AIDS and post-exposure treatment
Price
Copayment
Patient
71.26 RON
71.26 RON
0.00 RON